SACCHI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 7.639
EU - Europa 6.101
AS - Asia 1.421
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 4
AF - Africa 3
Totale 15.211
Nazione #
US - Stati Uniti d'America 7.585
IT - Italia 3.533
UA - Ucraina 1.014
SE - Svezia 534
TR - Turchia 520
CN - Cina 368
VN - Vietnam 338
IE - Irlanda 264
FI - Finlandia 244
DE - Germania 215
SG - Singapore 142
GB - Regno Unito 128
CZ - Repubblica Ceca 49
FR - Francia 49
CA - Canada 47
JP - Giappone 23
BE - Belgio 18
EU - Europa 18
BR - Brasile 11
RU - Federazione Russa 11
CH - Svizzera 10
CO - Colombia 6
EC - Ecuador 6
HK - Hong Kong 6
PK - Pakistan 6
NL - Olanda 5
RO - Romania 5
ES - Italia 4
IL - Israele 4
IN - India 4
MX - Messico 4
BD - Bangladesh 3
CU - Cuba 3
GR - Grecia 3
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
HU - Ungheria 2
ID - Indonesia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
EE - Estonia 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 15.211
Città #
Milan 2.433
Fairfield 966
Jacksonville 799
Chandler 698
Woodbridge 635
Ashburn 537
Seattle 391
Wilmington 391
Como 353
Houston 340
Ann Arbor 318
Dearborn 302
Princeton 297
Nyköping 295
Cambridge 286
Dublin 262
Izmir 262
Boardman 183
Dong Ket 181
Rome 155
Singapore 120
San Mateo 86
Beijing 85
San Diego 68
Ogden 54
Toronto 43
Chicago 40
Kocaeli 36
Washington 34
Hefei 32
Nanjing 29
Olomouc 27
Helsinki 26
Munich 25
Redmond 23
Tokyo 23
Kunming 22
Düsseldorf 21
Santa Clara 21
Brno 20
Brussels 18
Guangzhou 18
New York 18
London 17
Norwalk 17
Verona 17
Bursa 15
Redwood City 14
Dallas 13
Nanchang 13
Gavirate 12
Los Angeles 11
Jinan 10
Wenzhou 9
Changsha 8
Chengdu 7
Phoenix 7
Ponte Lambro 7
Zhengzhou 7
Falls Church 6
Fuzhou 6
Hebei 6
Hong Kong 6
Shenyang 6
Xian 6
Acton 5
Baotou 5
Barranquilla 5
Kilburn 5
Lugano 5
New Bedfont 5
Prescot 5
Augusta 4
Cairate 4
Chiswick 4
Frankfurt am Main 4
Islamabad 4
Petah Tikva 4
Shanghai 4
Timisoara 4
Varese 4
Besana in Brianza 3
Brighton 3
Casorezzo 3
Chongqing 3
Dhaka 3
Havana 3
Lappeenranta 3
Madrid 3
Parma 3
Pune 3
Samara 3
São Paulo 3
Trapani 3
Wandsworth 3
Wuhan 3
Amsterdam 2
Bergamo 2
Brasília 2
Budapest 2
Totale 11.317
Nome #
Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs 229
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 184
Biosensors for D-amino acid detection 182
Modulating D-amino acid oxidase substrate specificity: production of an enzyme for analytical determination of all D-amino acids by directed evolution 181
Characterization of human DAAO variants potentially related to an increased risk of schizophrenia 177
G72 primate-specific gene: a still enigmatic element in psychiatric disorders 177
The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. 169
Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction 163
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity 163
Human d-amino acid oxidase: The inactive G183R variant 163
D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy 159
Novel insights into renal d-amino acid oxidase accumulation: propiverine changes DAAO localization and peroxisomal size in vivo 156
Human D-Amino Acid Oxidase: Structure, Function, and Regulation 155
Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. 154
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex. 153
High-Throughput Screening Strategy Identifies Allosteric, Covalent Human D-Amino Acid Oxidase Inhibitor 153
Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility 153
Understanding renal nuclear protein accumulation: an in vitro approach to explain an in vivo phenomenon 153
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 153
Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus 151
Decreased free D-aspartate levels are linked to enhanced D-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 151
Characterization of human D-amino acid oxidase 150
Relevance of weak flavin binding in human D-amino acid oxidase 150
A biosensor for all D-amino acids using evolved D-amino acid oxidase 150
D-Serine and Glycine Differentially Control Neurotransmission during Visual Cortex Critical Period 148
Investigating the role of active site residues of Rhodotorula gracilis D-amino acid oxidase on its substrate specificity. 147
Determination of D-amino acids using a D-amino acid oxidase biosensor with spectrophotometric and potentiometric detection 145
Evidence for the interaction of d-amino acid oxidase with pLG72 in a glial cell line. 144
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line 143
Catalytic properties of D-amino acid oxidase in cephalosporin C bioconversion: A comparison between proteins from different sources 141
Structure-function relationships in human D-amino acid oxidase. 141
Is rat an appropriate animal model to study the involvement of d-serine catabolism in schizophrenia? insights from characterization of d-amino acid oxidase. 139
Reduced D-serine levels in the nucleus accumbens of cocaine-treated rats hinder the induction of NMDA receptor-dependent synaptic plasticity 139
Effect of ligand binding on human D-amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment 139
Optimization of glutaryl-7-aminocephalosporanic acid acylase expression in E.coli 138
Expression in Escherichia coli and in vitro refolding of the human protein pLG72 137
Engineering the Properties of D-Amino Acid Oxidases by a Rational and a Directed Evolution Approach. 131
Physiological functions of D-amino acid oxidases: from yeast to humans. 130
Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses 129
The freshwater cyanobacterium Planktothrix SP.FP1: molecular identification and detection of paralytic shellfish poisoning toxins 128
Modulation of the activity and stability of human D-amino acid oxidase by the interaction with small ligands. 128
Active site and reaction mechanism of Rhodotorula gracilis D-amino acid oxidase: a crystallographic and site-directed mutagenesis approach 128
The role of tyrosines 223 and 238 in Rhodotorula gracilis D-amino acid oxidase catalysis: Interpretation of double mutations 127
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 126
Biochemical properties of human D-amino acid oxidase variants and their potential significance in pathologies 125
Biochemical properties of human D-amino acid oxidase 124
Glycine oxidase from Bacillus subtilis: Role of Histidine 244 and Methionine 261. 120
The Freshwater Cyanobacterium Leptolymbya sp. FP1: PSP Toxins detection and genetic identification 118
Properties and applications of microbial D-amino acid oxidases: Current state and perspectives 116
Toxic cyanobacterial blooms in lake Varese (Italy): a multidisciplinary approach 115
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers 115
Could D-serine serum levels be considered a biomarker in Alzheimer’s disease? 114
Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. 114
Metabolism of the neuromodulator D-serine 112
Active site of yeast D-amino acid oxidase:mutations and inferences 111
Characterization of human DAAO variants potentially related to an increased risk to schizophrenia 110
Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex 107
Evolution of novel enzyme specificities from a common scaffold 107
Active site of yeast D-amino acid oxidase: mutations and inferences 106
Active site and reaction mechanism of Rhodotorula gracilis D-amino acid oxidase:a crystallographic and site-directed mutagenesis approach 104
DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia 104
Role of the highly conserved Tyr223 and Tyr238 of yeast D-amino acid oxidase 103
Deepening into the modulation of human D-amino acid oxidase 103
On the mechanism of Rhodotorula gracilis D-amino acid oxidase: role of the active site serine 335 102
Engineering the substrate specificity of D-amino-acid oxidase 101
D-amino acid oxidase variants related to human pathologies 101
Role of human DAAO in D-serine metabolism: new insight 99
Role of tyrosine 238 in the active site of Rhodotorula gracilis D-amino acid oxidase - A site-directed mutagenesis study 98
Structural basis of D-aspartate oxidase properties 98
Engineering the substrate specificity of D-amino acid oxidase: a rational design approach 96
Glia-derived D-serine governs NMDA receptor-dependent synaptic activity in the prefrontal cortex. 96
Enzyme factory: engineering of new biocatalysts strating from a common scaffold. 94
Cellular studies on human D-aspartate oxidase 94
Role of the highly conserved Tyr223 and Tyr238 of yeast D-amino acid oxidase 93
Engineering a new D-amino acid oxidase: an evoluted enzyme and its applications 92
Engineering the substrate specificity of D-amino acid oxidase by rational and irrational design 91
Examination of pLG72 and D-Amino Acid Oxidase interaction as molecular basis of Schizophrenia. 91
Structure and function of Rhodotorula gracilis D-amino acid oxidase. 1. Site-directed mutagenesis of tyrosines 223 and 238 90
Engineering the substrate specificity of D-amino acid oxidase: a directed evolution approach 90
Characterization of the G183R inactive human D-amino acid oxidase variant 89
pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase - Effect on schizophrenia susceptibility 88
Combinatorial and computational challenges to design the substrate specificity of D-amino acid oxidase 88
Rational design of a novel specificity of D-amino acid oxidase: towards the biosensor for all D-amino acids? 87
... And now saxitoxin-producing cyanobacteria in Europe 87
Insight into pLG72 and D-amino acid oxidase interaction 86
Role of R120 in the modulation of human D-amino acid oxidase 86
Investigating the molecular basis of schizophrenia: the effect of pLG72 interaction on the functionality of human D-amino acid oxidase 85
Investigating D-Amino Acid Oxidase and pLG72 as potential targets of the antipsychotic drug chlorpromazine. 83
Effect of binding of small ligands on the activity and stability of human D-amino acid oxidase:implications for the design of novel drugs for schizophrenia treatment 82
Enzyme factory: engineering of new biocatalysts strating from a common scaffold 81
Ligand-induced conformational changes in human D-amino acid oxidase 80
Characterization of human D-amino acid oxidase, a flavoenzyme involved in neurotransmission regulation 79
D-Serine metabolism in the brain: the role of D-amino acid oxidase 79
Serum D-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker 79
Detection of D-amino acids by D-amino acid oxidase. 78
Ligand-induced conformational changes in human D-amino acid oxidase 78
Structure and function of Rhodothorula gracilis D-amino acid oxidase. 1. Site-directed mutagenesis of tyrosine 223 and 238 78
Biocatalysis and biocatalyst production 77
pLG72-mediated modulation of hDAAO functionality: an intriguing issue 77
Toxic cyanobacterial blooms in Lake Varese: A multidisciplinary approach 77
Totale 12.035
Categoria #
all - tutte 58.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.883 0 0 0 0 163 317 427 350 164 232 53 177
2020/20212.106 40 194 55 204 50 216 61 184 330 220 209 343
2021/20221.449 181 197 101 77 101 36 94 107 72 179 120 184
2022/20231.898 170 89 153 213 154 441 7 240 253 76 47 55
2023/20243.695 592 590 630 653 720 219 15 48 93 31 17 87
2024/2025600 14 46 387 91 62 0 0 0 0 0 0 0
Totale 15.348